You are currently viewing a new version of our website. To view the old version click .

AGC Kinases and Cancer

Special Issue Information

AGC kinases are a group of related Ser/Thr protein kinases that acquired the acronym because of the structural similarities with protein kinase A, protein kinase G and protein kinase C at their catalytic domains. There are at least sixty members in the AGC kinase family, including Akt, 3-phosphoinositide-dependent kinase 1 (PDK1), protein kinase C (PKC), S6 kinase (S6K), serum- and glucocorticoid-induced protein kinase (SGK) and Rho-associated coiled-coil containing kinase (ROCK). AGC kinases play important roles in signal transduction and cell regulation. An aberration in several members of the AGC kinase family has been associated with cancer. Many of these AGC kinases exist as several different isoforms that exhibit distinct functions. Proper targeting of AGC kinases for cancer therapy requires a thorough understanding of the structure, function and regulation of different isoforms of a particular AGC kinase and the molecular mechanisms by which they contribute to cancer.  This Special Issue focuses on the involvement of AGC kinases, especially the function of individual isoforms of a particular AGC kinase, in cancer and as potential targets for cancer therapy.

Prof. Dr. Alakananda Basu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Akt/PKB
  • PDK1
  • PKC
  • RSK
  • S6K
  • SGK
  • ROCK

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694